See Cheng Yeo

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris et al. · Nephrology Dialysis Transplantation · 2024 · 77 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial

Jonathan Barratt, Adrian Liew, See Cheng Yeo et al. · Clinical Journal of the American Society of Nephrology · 2024 · 66 citations · Full text

Medicine, Immunology, Nephrology +17

Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study

Yong Pey See, Barnaby Edward Young, Li Wei Ang et al. · ˜The œNephron journals/Nephron journals · 2021 · 49 citations · Full text

Veterinary Medicine, Infectious Diseases, Nephrology +12

An Update on Current Therapeutic Options in IgA Nephropathy

Regina Shaoying Lim, See Cheng Yeo, Jonathan Barratt et al. · Journal of Clinical Medicine · 2024 · 39 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease

Gar Kay Hui, David W. Wright, Owen L. Vennard et al. · Biochemical Journal · 2015 · 28 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12